Human stem cell therapy could be on market in four years, researcher says

Recent Posts

• Improving CAR-T therapy from within
• ‘A cure on the horizon’: Are we finally close to ending type 1 diabetes?
• Scientists create “smart” DNA drug that targets cancer cells with extreme precision
• Patient deaths prompt concern over regenerative care not covered by insurance
• Biotech IPOs Rebound as AI Takes a More Central Role in Drug Development
• Clinical trial tests new cell therapy to manage kidney transplant rejection